Pricing Your Diagnostic: Why $500 and $25,000 Signal Very Different Things
Hermann Simon's research is clear: when buyers can't evaluate quality directly, price becomes the quality signal. A $500 assessment says "quick online quiz." A $25,000 assessment says "enterprise-grade evaluation." Here's how to price yours correctly.
A consultant I advise launched her proprietary assessment last year at $750. She'd spent eight months designing it — structured dimensions, weighted scoring, benchmarking data from her decade of client work. It was genuinely excellent.
Nobody bought it.
Not because it was too expensive. Because at $750, prospects assumed it was a glorified questionnaire — something they could approximate with a Google Form and a spreadsheet. The price told them it wasn't serious.
She relaunched at $5,000 with a 90-minute guided session, a detailed report, and benchmarking against industry data. Same diagnostic. Different price. Different market signal.
She sold twelve in the first quarter. Not because the diagnostic changed — because the price finally matched the value. Hermann Simon, in Confessions of the Pricing Man, explains the mechanism: price signals quality when buyers cannot evaluate quality directly. And in professional services, quality is always invisible before purchase.
The Price-Quality Signal
Why Underpricing Makes You Less Credible, Not More Competitive
Buyers of professional services face a fundamental problem: they can't test the product before they buy it. You can't preview a diagnostic the way you preview a movie trailer. You can't sample it the way you sample a wine. The quality is completely opaque until after you've paid.
In the absence of direct quality information, buyers use proxies. And the most powerful proxy available is price.
A $500 diagnostic lands in the same mental category as an online survey. Something quick. Something automated. Something that probably won't tell you anything you couldn't figure out yourself. Whether or not that's true doesn't matter — the price has already set expectations.
A $5,000 diagnostic lands in a different mental category entirely. This is an investment. This involves a real methodology. This produces output that justifies bringing to a leadership meeting. The price alone communicates seriousness — before the buyer has seen a single question.
A $25,000 diagnostic says: enterprise-grade. Board-ready output. Proprietary benchmarking data that can't be found elsewhere. Strategic recommendations backed by a depth of analysis that justifies executive attention.
Same assessment instrument, potentially. Completely different market perception at each price point. And completely different buyers attracted at each level.
Harry Beckwith captures this in Selling the Invisible: "Charge by the years, not by the hour." Your diagnostic draws on years — sometimes decades — of methodology development, pattern recognition, and industry expertise. The price should reflect the accumulated IP, not the time it takes to deliver.
The Three Price Tiers for Diagnostics
And What Each Tier Signals to the Market
Based on Simon's pricing research and Weiss's value-based fee principles, diagnostic pricing naturally falls into three tiers — each attracting a different buyer with different expectations:
Tier 1: The Credential Diagnostic ($1,000-$3,000). The buyer wants a score. They want to know where they stand. They want something they can reference in a presentation or an internal meeting. The output is a report — clear, professional, useful — but not deeply strategic. This tier attracts individual contributors, small business owners, and mid-level managers with departmental budgets. The engagement is efficient: perhaps a 60-minute guided session plus a standardized report.
Tier 2: The Strategic Diagnostic ($5,000-$15,000). The buyer wants insight. They don't just want a score — they want to understand what the score means, how they compare to peers, and what they should do about it. The output includes benchmarking, gap analysis, and prioritized recommendations. This tier attracts senior managers, VPs, and heads of departments with strategic budgets. The engagement includes a guided session, detailed analysis, a follow-up presentation, and often the beginning of a deeper relationship.
Tier 3: The Enterprise Diagnostic ($15,000-$50,000). The buyer wants transformation. The diagnostic isn't an endpoint — it's the first phase of a strategic initiative. The output includes multi-stakeholder assessment, cross-organizational benchmarking, executive-ready presentations, and a roadmap with specific milestones and resource requirements. This tier attracts C-suite executives, board members, and heads of transformation with enterprise budgets. The engagement is multi-week, involves multiple interviews and data collection streams, and produces output that directly informs capital allocation decisions.
The critical insight from Weiss: always present options top-down. Start with Tier 3. Simon's anchoring research confirms why: the first number a buyer sees becomes the reference point for everything that follows. When the first number is $25,000, a $7,500 option feels accessible. When the first number is $2,000, a $7,500 option feels extravagant.
Design all three tiers. Present all three in every sales conversation. Let the buyer choose their level of investment. You've converted the decision from "should I do this?" to "which level should I choose?" — and that's a fundamentally different and more productive conversation.
The One-Third Rejection Rule
How to Know Your Price Is Right
Ron Baker offers the sharpest pricing calibration tool I've encountered: roughly one-third of prospects should reject your diagnostic on price.
This feels uncomfortable. A third of your potential clients saying no? That seems like lost revenue.
It isn't. It's the signal that you're priced correctly.
If zero percent of prospects resist your pricing, you're underpriced. Every single person saying yes means there's significant money being left on the table — and more importantly, it means your price is low enough that buyers aren't associating it with premium quality.
If more than 60% resist, either your price is genuinely too high or — more commonly — your positioning hasn't established enough perceived value. The diagnostic might be excellent, but the market doesn't know that yet. The fix isn't lowering the price. It's improving the positioning.
At one-third rejection, you're in the sweet spot. You have enough demand at your current price that the rejections don't hurt. They simply filter for the clients who value what you offer most. And those clients — the ones who chose you despite the price — tend to be better engagements, more committed to the process, and more likely to continue into deeper work.
Track this formally. After every sales conversation involving the diagnostic, note whether price resistance appeared. Calculate your rejection rate monthly. Adjust only when the data tells you to — not when your fear tells you to.
Never Give Away the Full Diagnostic
The Most Expensive Mistake in Service Business Pricing
Blair Enns, in The Win Without Pitching Manifesto, is unequivocal: "Under no circumstances will we part with our thinking without appropriate compensation."
Baker adds: free diagnostics commoditize the highest-value step in your process.
The temptation is real. A prospect says: "We'd love to see the full assessment results before committing to a larger engagement." It feels reasonable. You want to demonstrate value. You want to build trust. So you give away the diagnostic for free, hoping to win the bigger project.
What actually happens is one of three things:
- They take the insights and implement internally. You've given them the diagnosis for free. They don't need you for the treatment — or at least, they think they don't. The engagement you were hoping to win never materializes.
- They use your diagnostic to shop for cheaper delivery. Now they have a clear picture of what needs to be done — from your assessment — and they use that clarity to negotiate with lower-cost providers who couldn't have produced the same analysis.
- They develop the expectation that your expertise should be free. Every future request will carry the implicit assumption that you'll give before you charge. The power dynamic shifts permanently in the buyer's favor.
A free sample of the diagnostic is different from a free diagnostic. Simon's freemium research shows that the free version should be genuinely useful but obviously incomplete — enough to create an "aha" moment, not enough to be actionable without the paid version. One dimension scored. No benchmarking. No recommendations. Enough to be interesting. Not enough to be sufficient.
Your diagnostic is the product. It's the most valuable moment in your entire client relationship — the moment where invisible problems become visible, where vague concerns become quantified gaps, where indecision transforms into urgency. Price it accordingly. The organizations that value a rigorous diagnosis are the ones worth serving. The ones that want it for free aren't your clients.